Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus
部位特异性抗血栓治疗:一项随机DESyne BDS Plus试验的24个月结果,该试验采用新型三药洗脱冠状动脉植入物,联合两种抗凝剂和西罗莫司。
期刊:Catheterization and Cardiovascular Interventions
影响因子:1.9
doi:10.1002/ccd.70106
Verheye, Stefan; Ferdinande, Bert; Bennett, Johan; Staico, Rodolfo; El-Jack, Seif; Tonino, Pim A L; Abizaid, Alexandre; Buysschaert, Ian; Scott, Douglas; Menon, Madhav; Wilkins, Gerard; McClean, Dougal; Kovarnik, Tomas; Christians, Uwe; Neylon, Antoinette; Mehmedbegovic, Zlatko; Smits, Pieter C; Morice, Marie-Claude; Webster, Mark